Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Int J Androl 11:479491
High-risk patient factors include active gastrointestinal symptoms (odds ratio 7.66, 95% confidence interval 3.4217.17), early treatment phase (less than 4 weeks), higher medication doses, pre-existing diabetic gastroparesis, obesity (BMI greater than 30), and gastroesophageal reflux disease [31]
Regulation of cystathionine gamma-lyase in mammalian cells by hypoxia
Frontiers in Pharmacology (2022) 5
US$ 23.56
US$ 22.89
US$ 28.69
